⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 1984Antimicrobial Agents and ChemotherapyOpen Access

In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)

Rao Prabhala B. Dharma Rao Rosemarie Marshall Madhu B. Bansal H Thadepalli

View Full Paper

Ask AI

Bookmark

Share

Abstract

About 80% of 70 clinical isolates of Bacteroides fragilis were inhibited by 4 micrograms of ciprofloxacin (Bay o 9867) per ml. The 90% MIC of ciprofloxacin was 8 micrograms/ml for other Bacteroides species, 2 micrograms/ml for Peptococcus species, 8 micrograms/ml for Peptostreptococcus species, and 16 micrograms/ml for Clostridium and Eubacterium species.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Prabhala et al. (1984) studied this question.

synapsesocial.com/papers/6a8333a888eff2bd7befeefd https://doi.org/10.1128/aac.26.5.785

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coliAntimicrobial Agents and Chemotherapy · Wed,
2Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinationsAntimicrobial Agents and Chemotherapy · Wed,
3Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones disseminationAntimicrobial Agents and Chemotherapy · Wed,
4A multivalent CPS-CRM197 conjugate vaccine protects against severe/fatal Klebsiella pneumoniae disease in a mouse infection modelAntimicrobial Agents and Chemotherapy · Wed,
5In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infectionsAntimicrobial Agents and Chemotherapy · Thu,

More from Antimicrobial Agents and Chemotherapy

Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis -derived fungal metabolite targeting pyruvate kinase IITue,
Pharmacokinetic/pharmacodynamic evaluation of multidose oritavancin for prolonged durations of therapyWed,
A machine learning framework for precision dosing of daptomycin across diverse disease statesWed,
Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill womenWed,
In vitro activity of gepotidacin against baseline Neisseria gonorrhoeae phenotypes and genotypes recovered from a clinical trial for uncomplicated urogenital gonorrhea (EAGLE-1)Wed,